跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
露达舒 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Loteprednol Etabonate Ophthalmic Suspension
Approved
化学药品
Loteprednol Etabonate Ophthalmic Suspension
Bausch & Lomb Incorporated
🇨🇳 National Medical Products Administration
Approval Date
Nov 4, 2024
Approval ID
8iDnpZM4Czd
Company
Bausch & Lomb Incorporated
Type
化学药品
Approval Details
Approval Id
8iDnpZM4Czd
Approval Number
国药准字HJ20160346
Generic Name
氯替泼诺混悬滴眼液
Generic Name En
Loteprednol Etabonate Ophthalmic Suspension
Trade Name
露达舒
Drug Type
化学药品
Dosage Form
眼用制剂
Strength
0.5%(5ml:25mg)
Reg Date
2024-11-04
Expired Date
2029-11-03
Company Name
Bausch & Lomb Incorporated
Production Company Name
Bausch & Lomb Incorporated
Company Detail Path
/organization/bausch-and-lomb-incorporated
Production Company Detail Path
/organization/bausch-and-lomb-incorporated
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 4, 2024
Approval ID
8iDnpZM4Czd
Type
化学药品
Back to NMPA Approvals
